A resolution to the war in Ukraine could reduce geopolitical uncertainty and boost markets.These stocks were poised to make moves Monday:Dayforce jumped 26% after Bloomberg reported that ...

The upward revision follows Warren Buffett’s Berkshire Hathaway’s (NYSE: BRK.A) recent $1.6 billion investment in UnitedHealth.

The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a [form of liver disease]( ...

This investment signifies Buffett's re-entry into UNH after liquidating his entire position back in 2010, indicating that he perceives significant value at ...

If any investor has stood the test of time, it is Warren Buffett, and with good reason. For years, the “Oracle of Omaha” has had a rock-star-like presence in the investing world, and his annual ...

UnitedHealth Group Inc. (NYSE:UNH) extended its rebound Monday, climbing another 3% in premarket trading after soaring 12% on ...

Today’s Forbes Daily newsletter covers the real impact from a $250 U.S. visa fee, Elon Musk and Sam Altman’s feud, Warren ...

Wall Street's main indexes rallied over the past two weeks, with the blue-chip Dow hitting an intra-day record high on Friday ...

Wall Street's main indexes rallied over the past two weeks, with the blue-chip Dow hitting an intra-day record high on Friday ...

The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a form of liver disease.

Fresh off a 12% surge on the news that Warren Buffett's Berkshire Hathaway, as well as other leading investors, purchased the ...